LivaNova PLC (NASDAQ:LIVN) Hits New 52-Week High on Strong Earnings

Evrard Martin
Août 11, 2017

Legal & General Group Plc's holdings in LivaNova PLC were worth $842,000 at the end of the most recent reporting period.

Franklin Resources Inc increased its investment in LivaNova PLC - Ordinary Shares by 7.7% in the last quarter.

As of the end of the quarter Martingale Asset Management L P had sold 6,706 shares trimming its position 65.1%. Mason Street Advisors LLC now owns 20,484 shares of the company's stock worth $1,004,000 after buying an additional 64 shares in the last quarter. Norges Bank purchased a new position in shares of LivaNova PLC during the fourth quarter valued at about $14,987,000. Dimensional Fund Advisors LP increased its stake in shares of LivaNova PLC by 0.8% in the fourth quarter. The institutional investor owned 8,150 shares of the company's stock after buying an additional 650 shares during the period. Louisiana State Employees Retirement System boosted its position in shares of LivaNova PLC by 0.9% in the first quarter. Finally, Bollard Group LLC purchased a new position in shares of LivaNova PLC during the first quarter valued at about $1,715,000. Institutional investors own 73.41% of the company's stock. The stock had a trading volume of 964,932 shares. Shares are trading at $62.19 which is marginally higher than the 50 day moving average of $61.63 and which is impressively higher than the 200 day moving average of $54.97. LivaNova PLC has a 52 week low of $40.83 and a 52 week high of $64.95. The firm's market cap is $3.04 billion.

LivaNova PLC (NASDAQ:LIVN)'s share price hit a new 52-week high on Wednesday after the company announced better than expected quarterly earnings.

As of the latest earnings report the EPS was $-0.23 and is projected to be $3.14 for the current year with 48,838,000 shares now outstanding. The firm had revenue of $321.40 million during the quarter, compared to analysts' expectations of $315.75 million. The value of the total investment in LivaNova PLC - Ordinary Shares increased from $594,000 to $596,000 a change of 0.3% since the last quarter. The business's quarterly revenue was up.1% compared to the same quarter previous year. On average, analysts anticipate that LivaNova PLC will post $3.14 earnings per share for the current year. If you are accessing this news story on another publication, it was illegally copied and republished in violation of United States & worldwide copyright & trademark legislation. The legal version of this news story can be viewed at

There has been some buying and selling insider activity on LivaNova PLC - Ordinary Shares (NASDAQ:LIVN) recently. The shares were acquired at an average cost of $58.58 per share, with a total value of $58,580.00. Following the transaction, the director now owns 1,000 shares in the company, valued at approximately $58,580. The acquisition was disclosed in a filing with the SEC, which can be accessed through this link. In the last three months, insiders have sold 3,000 shares of company stock valued at $180,840. The Director now owns $703,050 of the stock per an SEC filing yesterday.

LivaNova PLC, a medical technology company, design, develops, manufactures, and sells therapeutic solutions worldwide. The Company's segments include Cardiac Surgery, Cardiac Rhythm Management, Neuromodulation and Other. The Cardiac Surgery segment develops, produces, and sells cardiovascular surgery products, including oxygenators, heart-lung machines, perfusion tubing systems, cannulae and accessories, and systems for autotransfusion and autologous blood washing, as well as surgical tissue and mechanical valve replacements, and fix products for damaged or diseased heart valves primarily for perfusionists and cardiac surgeons.

D'autres rapports CampDesrEcrues

Discuter de cet article